ESC Premium Access

Anticoagulation for cardioversion of atrial fibrillation: exploring areas of uncertainty

Event: ESC CONGRESS 2017
Topic: Atrial fibrillation (AF)
Session type: Symposium
Date: 28 August 2017
Time: 16:30 - 18:00

Congress Session

4 presentations in this session

Early cardioversion: is there strong evidence to support the concept?

Speaker: Professor P. Kirchhof (Hamburg, DE)

Practical considerations for cardioversion of atrial fibrillation.

Speaker: Doctor R. Cappato (Milan, IT)

Dealing with left atrial appendage clot

Speaker: Doctor F. Marin (Murcia, ES)

Non-vitamin K oral anticoagulants for cardioversion: recent trials.

Speaker: Professor M. Ezekowitz (Philadelphia, US)

4 speakers from this session

Professor Paulus Kirchhof

University Heart & Vascular Center Hamburg, Hamburg (Germany)
43 presentations
1 follower

Doctor Riccardo Cappato

Humanitas Research Hospital, Milan (Italy)
12 presentations
0 follower

Doctor Francisco Marin

Hospital Universitario Virgen Arrixaca, Murcia (Spain)
2 presentations
0 follower

Professor Michael D Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk